(Q28268061)

English

The concept of synthetic lethality in the context of anticancer therapy

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

1 reference

Europe PubMed Central

The concept of synthetic lethality in the context of anticancer therapy (English)

0 references

William G. Kaelin

1

object named as

William G Kaelin

0 references

language of work or name

0 references

publication date

September 2005

0 references

Nature Reviews Cancer

0 references

5

0 references

9

0 references

689-98

0 references

Systematic genetic analysis with ordered arrays of yeast deletion mutants

1 reference

https://api.crossref.org/works/10.1038/NRC1691

21 April 2017

Global mapping of the yeast genetic interaction network

1 reference

https://api.crossref.org/works/10.1038/NRC1691

21 April 2017

Proliferation, cell cycle and apoptosis in cancer

1 reference

https://api.crossref.org/works/10.1038/NRC1691

21 April 2017

Hsp90 as a capacitor for morphological evolution

1 reference

https://api.crossref.org/works/10.1038/NRC1691

21 April 2017

Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase

1 reference

https://api.crossref.org/works/10.1038/NRC1691

21 April 2017

Cdk2 knockout mice are viable

1 reference

https://api.crossref.org/works/10.1038/NRC1691

21 April 2017

Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways

1 reference

https://api.crossref.org/works/10.1038/NRC1691

21 April 2017

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1038/NRC1691

21 April 2017

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://api.crossref.org/works/10.1038/NRC1691

21 April 2017

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

1 reference

https://api.crossref.org/works/10.1038/NRC1691

21 April 2017

Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR.

1 reference

https://api.crossref.org/works/10.1038/NRC1691

21 April 2017

High-throughput screening of small molecules in miniaturized mammalian cell-based assays involving post-translational modifications

1 reference

https://api.crossref.org/works/10.1038/NRC1691

21 April 2017

Establishment of a chemical synthetic lethality screen in cultured human cells

1 reference

https://api.crossref.org/works/10.1038/NRC1691

21 April 2017

Systematic functional analysis of the Caenorhabditis elegans genome using RNAi

1 reference

https://api.crossref.org/works/10.1038/NRC1691

21 April 2017

Toward improving Caenorhabditis elegans phenome mapping with an ORFeome-based RNAi library

1 reference

https://api.crossref.org/works/10.1038/NRC1691

21 April 2017

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

1 reference

https://api.crossref.org/works/10.1038/NRC1691

21 April 2017

A system for stable expression of short interfering RNAs in mammalian cells

1 reference

https://api.crossref.org/works/10.1038/NRC1691

21 April 2017

Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells

1 reference

https://api.crossref.org/works/10.1038/NRC1691

21 April 2017

A large-scale RNAi screen in human cells identifies new components of the p53 pathway

1 reference

https://api.crossref.org/works/10.1038/NRC1691

21 April 2017

Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis

1 reference

https://api.crossref.org/works/10.1038/NRC1691

21 April 2017

Protein degradation and protection against misfolded or damaged proteins

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

21 April 2017

Cancer. Addiction to oncogenes--the Achilles heal of cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

21 April 2017

Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

21 April 2017

A DNA vector-based RNAi technology to suppress gene expression in mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

21 April 2017

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

21 April 2017

Choosing anticancer drug targets in the postgenomic era.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Using cancer genetics to guide the selection of anticancer drug targets

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Gleevec: prototype or outlier?

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Principles for the buffering of genetic variation

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Synthetic enhancement in gene interaction: a genetic tool come of age.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Mutation load, functional overlap, and synthetic lethality in the evolution and treatment of cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Emerging uses for genomic information in drug discovery

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

From large networks to small molecules

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Synthetic dosage lethality

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Isolation of ORC6, a component of the yeast origin recognition complex by a one-hybrid system

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Integrating genetic approaches into the discovery of anticancer drugs

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Role of the retinoblastoma protein in the pathogenesis of human cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

E2F-1 cooperates with topoisomerase II inhibition and DNA damage to selectively augment p53-independent apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Chemosensitivity linked to p73 function

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Heat shock protein 90 as a molecular target for cancer therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Altered states: selectively drugging the Hsp90 cancer chaperone

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Heat-shock protein 90 inhibitors as novel cancer chemotherapeutics - an update

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Proteasome inhibition as a novel therapeutic target in human cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Differential regulation of E2F transactivation by cyclin/cdk2 complexes

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Proteasome-mediated destruction of the cyclin a/cyclin-dependent kinase 2 complex suppresses tumor cell growth in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Proliferation of cancer cells despite CDK2 inhibition.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Caffeine-induced uncoupling of mitosis from the completion of DNA replication in mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

The synthesis of protein(S) for chromosome condensation may be regulated by a post-transcriptional mechanism

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

ATR is a caffeine-sensitive, DNA-activated protein kinase with a substrate specificity distinct from DNA-PK.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

ATR inhibition selectively sensitizes G1 checkpoint-deficient cells to lethal premature chromatin condensation

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Linking molecular therapeutics to molecular diagnostics: inhibition of the FRAP/RAFT/TOR component of the PI3K pathway preferentially blocks PTEN mutant cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Consequences of nonadaptive alterations in cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Gene deletion: a new target for cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Frequency of homozygous deletion at p16/CDKN2 in primary human tumours

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Status of methylthioadenosine phosphorylase and its impact on cellular response to L-alanosine and methylmercaptopurine riboside in human soft tissue sarcoma cells.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Combining biological networks to predict genetic interactions

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Use of isogenic human cancer cells for high-throughput screening and drug discovery

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Genetic synthetic lethality screen at the single gene level in cultured human cells

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

F16, a mitochondriotoxic compound, triggers apoptosis or necrosis depending on the genetic background of the target carcinoma cell

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

A novel mitochondriotoxic small molecule that selectively inhibits tumor cell growth.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Synthetic lethal targeting of MYC by activation of the DR5 death receptor pathway

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Chemical genomic profiling of biological networks using graph theory and combinations of small molecule perturbations

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Systematic discovery of multicomponent therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Drug-like properties and the causes of poor solubility and poor permeability

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitors.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Immunophilin ligands demonstrate common features of signal transduction leading to exocytosis or transcription

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Yeast genome-wide drug-induced haploinsufficiency screen to determine drug mode of action

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Genomic profiling of drug sensitivities via induced haploinsufficiency.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Drug target validation and identification of secondary drug target effects using DNA microarrays

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

lin-35 and lin-53, two genes that antagonize a C. elegans Ras pathway, encode proteins similar to Rb and its binding protein RbAp48.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

lin-35/Rb and ubc-18, an E2 ubiquitin-conjugating enzyme, function redundantly to control pharyngeal morphogenesis in C. elegans

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

fzr-1 and lin-35/Rb function redundantly to control cell proliferation in C. elegans as revealed by a nonbiased synthetic screen

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Synthetic lethality of retinoblastoma mutant cells in the Drosophila eye by mutation of a novel peptidyl prolyl isomerase gene

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Genome-wide RNAi screen reveals a specific sensitivity of IRES-containing RNA viruses to host translation inhibition

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

RNAi and HTS: exploring cancer by systematic loss-of-function

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Stable suppression of tumorigenicity by virus-mediated RNA interference

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

A resource for large-scale RNA-interference-based screens in mammals.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Enzymatic production of RNAi libraries from cDNAs.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Identification of Modulators of TRAIL-Induced Apoptosis via RNAi-Based Phenotypic Screening

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Microarrays of small molecules embedded in biodegradable polymers for use in mammalian cell-based screens.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

RNAi living-cell microarrays for loss-of-function screens in Drosophila melanogaster cells.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

DNA helicase gene interaction network defined using synthetic lethality analyzed by microarray

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Quantitative phenotypic analysis of yeast deletion mutants using a highly parallel molecular bar-coding strategy

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Characterization of synthetic DNA bar codes in Saccharomyces cerevisiae gene-deletion strains

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Simultaneous identification of bacterial virulence genes by negative selection.

1 reference

https://api.crossref.org/works/10.1038%2FNRC1691

31 March 2020

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28268061&oldid=2175169552"